John L. Wallace, n/a

Chief Scientific Officer
Antibe Therapeutics Inc.
Toronto, Ontario, Canada

Presentation(s):

• Poster Number-27 - Potent anti-inflammatory effects of an H2S-releasing naproxen (ATB-346) in a human model of inflammation

  Poster Abstracts